Nonalcoholic fatty liver disease (NAFLD) is a liver manifestation of metabolic syndrome.
Overconsumption of high-fat diet (HFD) and increased intake of sugar-sweetened …

Non-alcoholic fatty liver disease (NAFLD) is a frequent accompaniment of obesity and
insulin resistance. With the prevalence approaching 85% in obese populations, new …

A carbohydrate-restricted diet is a widely recommended intervention for non-alcoholic fatty
liver disease (NAFLD), but a systematic perspective on the multiple benefits of this diet is …

Nonalcoholic steatohepatitis (NASH), the lynchpin between steatosis and cirrhosis in the
spectrum of nonalcoholic fatty liver disorders (NAFLD), was barely recognized in 1981 …

Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized cause of liver
disease in the United States and worldwide. With obesity being an important risk factor …

The lumen of the gastrointestinal (GI) tract is home to an enormous quantity of different
bacterial species, our microbiota, that thrive in an often symbiotic relationship with the host …

A link between dietary fructose intake, gut‐derived endotoxemia, and nonalcoholic fatty liver
disease (NAFLD) has been suggested by the results of human and animal studies. To …

METHODS—A Medline search without limitations of date (as of October 2005), language, or
humans was carried out by the authors. The following medical subject headings were …

NAFLD/NASH is a sex‐dimorphic disease, with a general higher prevalence in men. Women
are at reduced risk of NAFLD compared to men in fertile age, whereas after menopause …

Type 2 diabetes and cardiovascular disease represent a serious threat to the health of the
population worldwide. Although overall adiposity and particularly visceral adiposity are …